AzTrials
AzTrials

Trauma (Including Fractures)Phase 3NCT07580976

Tru-Vu Wrist Positioning Aid Multi-Center Implementation Within NLHS

A Phase 3 study testing Tru Vu tool and training in people with Trauma (Including Fractures) and Arthritis, run by Western University at 3 sites in Canada.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study has two primary aims: 1) to determine whether a novel wrist x-ray positioning aid can be implemented within 3 different healthcare centers in Newfoundland and Labrador, and 2) to determine the ability of the tool to improve patient positioning in wrist x-rays. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Trauma (Including Fractures), Arthritis
What is being tested?
Tru Vu tool and training
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,800 participants
Where
3 sitesCanada
Study dates
14 Jun 2026to 1 Sep 2027
Phase
Phase 3
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Must be 18 years of age or older
  • Must be proficient in English (reading/writing)
  • Must have been referred for wrist imaging at one of the following healthcare centers: Health Sciences Center (St. John's, NL), Bonne Bay Health Center (Norris Point, NL), or Labrador Health Center (Happy Valley-Goose Bay, NL).

Who cannot join

  • Incapable of providing informed consent

Trial locations and contacts

3 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Canada3 sites
  • Labrador Health Centre

    Happy Valley-Goose Bay, Labrador, A0P1C0

    Emily Lalone, PhD, 519-661-2111 ext. 88243, emily.lalone@uwo.ca

  • Bonne Bay Health Centre

    Norris Point, Newfoundland and Labrador, A8A3L1

    Emily Lalone, PhD, 519-661-2111 ext. 88243, emily.lalone@uwo.ca

  • Health Sciences Centre

    St. John's, Newfoundland and Labrador, A1B3V6

    Emily Lalone, PhD, 519-661-2111 ext. 88243, emily.lalone@uwo.ca

Other trials in Canada

About this study

This study has two primary aims: 1) to determine whether a novel wrist x-ray positioning aid can be implemented within 3 different healthcare centers in Newfoundland and Labrador, and 2) to determine the ability of the tool to improve patient positioning in wrist x-rays. It will also learn about the number of repeat x-rays required with or without the use of the tool and radiographer confidence. The main questions it aims to answer are:

  1. Will the implementation of the Tru-Vu differ between an urban health center, rural clinic, and remote regional hospital?
  2. Can the Tru-Vu improve the positioning procedure for radiographers performing wrist x-rays, resulting with more useful x-rays.
Read more

Researchers will compare x-rays before and after the implementation of the tool as well as between centers.

Technologist participants will:

  • Use the tool during the positioning procedure for wrist x-rays.
  • Provide feedback regarding tool use and perceived implementation barriers and facilitators.
Being tested
Tru Vu tool and training
Medical subject headings
Wounds and Injuries, Arthritis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Tru Vu tool and trainingDevice

    A positioning aid and training videos for wrist x-rays

Study groups in NCT07580976
Study groupRoleWhat they receive
Urban hospitalExperimentalRadiographs will be retrospectively collected and compared to radiographs captured after the implementation of the tool. Additional radiographs will be collected over a 6-month follow-up period.
Receives: Device: Tru Vu tool and training
Rural health centerExperimentalRadiographs will be retrospectively collected and compared to radiographs captured after the implementation of the tool. Additional radiographs will be collected over a 6-month follow-up period.
Receives: Device: Tru Vu tool and training
Regional remote hospitalExperimentalRadiographs will be retrospectively collected and compared to radiographs captured after the implementation of the tool. Additional radiographs will be collected over a 6-month follow-up period.
Receives: Device: Tru Vu tool and training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Radiograph grading score

    Radiographs collected retrospectively and prospectively will be graded by a radiologist and radiographer

    Measured: Radiographs will be collected retrospectively 4 months prior to implementation and 6 months prospectively after the implementation of the tool.

  2. Tool adoption (and associated implementation outcomes)

    A survey will collect perceived tool use and other perceived implementation outcomes (including fidelity, appropriateness, acceptability, and adoption).

    Measured: The survey will be administered 6 months after the implementation of the tool and training.

Secondary outcomes (2)
  1. Sustainability

    Post-follow up survey will be conducted 6 months after the end of the implementation period and will collect perceived tool use.

    Measured: 6 months after the conclusion of the implementation period

  2. Repeated radiographs

    Document the number of repeat radiographs captured.

    Measured: Repeat radiographs will be collected and compared 4 months retrospectively prior to implementation and 6 months after the start of implementation.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 May 2026
  2. Study start14 Jun 2026 (estimated)
  3. Primary completion1 Feb 2027 (estimated)
  4. Study completion1 Sep 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
1,800 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07580976
Sponsor's protocol ID
129141
Status last verified
May 2026
First submitted
5 May 2026
Last updated
18 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing Tru Vu tool and training in people with Trauma (Including Fractures) and Arthritis, run by Western University at 3 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 18 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Emily Lalone, PhD (519-661-2111 ext. 88243, emily.lalone@uwo.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Radiograph grading score (time frame: Radiographs will be collected retrospectively 4 months prior to implementation and 6 months prospectively after the implementation of the tool.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 May 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in